John F. Gerster
- Epidemiology top 10%
- Molecular Biology
- Immunology top 10%
- Organic Chemistry top 10%
- Dermatology top 5%
- Co-authors
- Richard L. MillerRoland K. RobinsMark A. TomaiMary OwensHerbert B. SladeMichael J. ReiterLinda M. ImbertsonLeroy B. Townsend
- Topics
- Synthesis and Characterization of Heterocyclic Compounds (6 papers)Synthesis and Biological Evaluation (6 papers)Biochemical and Molecular Research (3 papers)
- Cited by
- ImmunologyDermatologyPhysiology
- Journals
- Journal of the American Chemical SocietyJournal of Medicinal ChemistryAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesCanada
In The Last Decade
John F. Gerster
21 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Epidemiology 413
- Molecular Biology 354
- Immunology 342
- Organic Chemistry 253
- Dermatology 143
Countries citing papers authored by John F. Gerster
This map shows the geographic impact of John F. Gerster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Gerster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Gerster more than expected).
Fields of papers citing papers by John F. Gerster
This network shows the impact of papers produced by John F. Gerster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Gerster. The network helps show where John F. Gerster may publish in the future.
Co-authorship network of co-authors of John F. Gerster
This figure shows the co-authorship network connecting the top 25 collaborators of John F. Gerster. A scholar is included among the top collaborators of John F. Gerster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Gerster. John F. Gerster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 333 | |
| 3 | 102 | |
| 4 | 216 | |
| 5 | 31 | |
| 6 | 14 | |
| 7 | 6 | |
| 8 | 41 | |
| 9 | 19 | |
| 10 | 17 | |
| 11 | 25 | |
| 12 | 14 | |
| 13 | 20 | |
| 14 | 13 | |
| 15 | 39 | |
| 16 | 29 | |
| 17 | 77 | |
| 18 | 42 | |
| 19 | 1 | |
| 20 | 27 |
About John F. Gerster
John F. Gerster is a scholar working on Organic Chemistry, Molecular Medicine and Pharmaceutical Science, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (6 papers), Synthesis and Biological Evaluation (6 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Immunology (342 citations), Dermatology (143 citations) and Physiology (65 citations). John F. Gerster has collaborated with scholars based in United States and Canada. Frequent co-authors include Richard L. Miller, Roland K. Robins, Mark A. Tomai, Mary Owens, Herbert B. Slade, Michael J. Reiter, Linda M. Imbertson, Leroy B. Townsend, Jesse W. Jones and Sheila J. Gibson. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.